Table 5.
Positive HIV peptides after HIV CE DNA vaccination and after rMVA62B boost
| Gag peptides with positive ELISpot responses | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5698 | 5699 | 5700 | 5701 | 5702 | 5703 | |||||||||
| Gag Peptidea | CE + gag | MVA | CE + gag | MVA | CE + gag | MVA | CE + gag | MVA | CE + gag | MVA | CE + gag | MVA | ||
| 41 | EKAFSPEVIPMFSAL | CE2 | + | + | + | + | + | + | + | |||||
| 43 | IPMFSALSEGATPQD | CE2 | + | + | + | + | + | + | ||||||
| 44 | SALSEGATPQDLNTM | CE2 | + | + | + | + | + | + | ||||||
| 49 | GHQAAMQMLKETINE | CE3 | + | |||||||||||
| 50 | AMQMLKETINEEAAE | CE3 | + | + | + | + | + | + | + | |||||
| 51 | LKETINEEAAEWDRV | CE3 | + | + | ||||||||||
| 53 | AAEWDRVHPVHAGPI | Variableb | + | + | + | + | + | |||||||
| 54 | DRVHPVHAGPIAPGQ | Variableb | + | + | + | + | + | + | ||||||
| 58 | REPRGSDIAGTTSTL | CE4 | + | + | + | + | ||||||||
| 59 | GSDIAGTTSTLQEQI | CE4 | + | |||||||||||
| 60 | AGTTSTLQEQIGWMT | CE4 | + | + | + | + | ||||||||
| 65 | PVGEIYKRWIILGLN | CE5 | + | + | ||||||||||
| 66 | IYKRWIILGLNKIVR | CE5 | + | + | + | + | + | |||||||
| 67 | WIILGLNKIVRMYSP | CE5 | + | + | + | + | ||||||||
| 68 | GLNKIVRMYSPTSIL | CE5 | + | + | + | + | + | + | + | + | ||||
| 69 | IVRMYSPTSILDIRQ | CE5 | + | + | + | + | + | |||||||
| 75 | VDRFYKTLRAEQASQ | CE6 | + | + | + | |||||||||
| 76 | YKTLRAEQASQEVKN | CE6 | + | + | ||||||||||
Number of HIV HXB2 p55Gag peptide (15-mer overlapping by 11 AA).
Peptides covering the variable region between CE3 and CE4.